Teva- Pharmaceutical Industries Intangible Assets

As of the most recent data (March 2026), TEVA shows a intangible assets of $3.6B. That compares with $4.2B in the prior-year period — down 13.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TEVA's intangible assets is now $3.6B (was $4.2B) — a 13.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.

Tracking TEVA's intangible assets over time shows whether Teva- Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $3.6B That compares with $4.2B in the prior-year period — down 13.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $3.6B) with ownership activity and broader fundamentals.

Teva- Pharmaceutical Industries's intangible assets is $3.6B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.